Does Rallies show 13F holders for CLNN?

Yes. Rallies tracks hedge fund and 13F ownership data for CLNN, including fund names, share counts, latest tracked quarter, and position changes when available.

Is CLNN research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CLNN. It does not provide personalized investment advice.

CLNN (Clene Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Clene Inc. Common Stock (CLNN) is a publicly traded Healthcare sector company. As of May 21, 2026, CLNN trades at $6.72 with a market cap of $86.76M and a P/E ratio of -1.19. CLNN moved +7.60% today. Year to date, CLNN is +19.79%; over the trailing twelve months it is +165.38%. Its 52-week range spans $2.28 to $13.50. Analyst consensus is strong buy with an average price target of $32.20. Rallies surfaces CLNN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns CLNN stock?

Hedge funds tracked by Rallies that own CLNN include Two Sigma, Citadel Advisors, and Renaissance Technologies. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Clene Inc. Common Stock.

CLNN Key Metrics

Key financial metrics for CLNN
Metric	Value
Price	$6.72
Market Cap	$86.76M
P/E Ratio	-1.19
EPS	$-5.67
Dividend Yield	0.00%
52-Week High	$13.50
52-Week Low	$2.28
Volume	201
Avg Volume	0
Revenue (TTM)	$342.00K
Net Income	$-39.40M
Gross Margin	79.53%

Top Hedge Funds Holding CLNN

Two Sigma holds 53.64K shares of CLNN, changed +70.32% as of Jun 30, 2024.
Citadel Advisors holds 20.84K shares of CLNN, changed -46.00% as of Dec 31, 2024.
Renaissance Technologies holds 18.04K shares of CLNN, changed +45.48% as of Dec 31, 2024.

Latest CLNN News

Clene Eyes Q3 2026 CNM-Au8 NDA After Positive FDA Meeting, Raises $35M — May 14, 2026
Clene Prices $7M Offering of 1M Shares at $7 Per Share for NDA Filing — May 5, 2026
Clene Secures $28M Oversubscribed Financing, Eyes NDA Filing by June — Mar 12, 2026
Clene Secures $28M Oversubscribed Offering to Fund NDA, Extend Runway into 2027 — Jan 9, 2026
Clene Inc.’s Chidozie Offloads 3,938 Shares at $6.29 After Prior $6.03 Sale — Jan 9, 2026

Recent CLNN Insider Trades

Ugwumba Chidozie sold 73.30K (~$454.44K) on May 12, 2026.
Ugwumba Chidozie sold 22.18K (~$149.69K) on May 11, 2026.
Ugwumba Chidozie sold 72.88K (~$495.61K) on May 4, 2026.

CLNN Analyst Consensus

5 analysts cover CLNN: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $32.20.

Common questions about CLNN

Who owns CLNN stock?: Hedge funds tracked by Rallies that own CLNN include Two Sigma, Citadel Advisors, and Renaissance Technologies. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Clene Inc. Common Stock.
Does Rallies show 13F holders for CLNN?: Yes. Rallies tracks hedge fund and 13F ownership data for CLNN, including fund names, share counts, latest tracked quarter, and position changes when available.
Is CLNN research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CLNN. It does not provide personalized investment advice.